The Catastrophic Antiphospholipid (Asherson's) Syndrome in 2004—a review

Harris, 1987, Clinical and serological features of the antiphospholipid syndrome (APS), Br. J. Rheumatol., 26, 19 Asherson, 1992, The catastrophic antiphospholipid antibody syndrome, J. Rheumatol., 19, 508 Piette, 2003, The catastrophic antiphospholipid syndrome—Asherson's syndrome, Ann. Med. Internet, 154, 195 Bird, 1987, Disseminated intravascular coagulation, antiphospholipid antibodies and ischemic necrosis of the extremities, Ann. Rheum. Dis., 46, 251, 10.1136/ard.46.3.251 Ingram, 1987, An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies. Report of two cases, Arthritis Rheum., 30, 1167, 10.1002/art.1780301013 Greisman, 1991, Occlusive vasculopathy in systemic lupus erythematosus—association with anticardiolipin antibody, Arch. Intern. Med., 151, 389, 10.1001/archinte.151.2.389 Harris, 1991, An acute disseminated coagulopathy–vasculopathy associated with the antiphospholipid syndrome, Arch. Intern. Med., 151, 231, 10.1001/archinte.151.2.231 Asherson, 1998, Catastrophic antibody syndrome. Clinical and laboratory features of 50 patients, Medicine (Baltimore), 77, 195, 10.1097/00005792-199805000-00005 Asherson, 2001, Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients, Medicine (Baltimore), 80, 355, 10.1097/00005792-200111000-00002 Asherson, 2000, The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry?, J. Rheumatol., 27, 12 Gharavi, 1999, Induction of antiphospholipid antibodies by immunization with viral peptides, Lupus, 8, 449, 10.1177/096120339900800607 Gharavi, 2000, New developments in viral peptides and antiphospholipid antibody induction, J. Autoimmun., 15, 227, 10.1006/jaut.2000.0403 Kitchens, 1998, Thrombotic storm: when thrombosis begets thrombosis, Am. J. Med., 104, 381, 10.1016/S0002-9343(98)00061-8 Amital, 2001, Catastrophic antiphospholipid syndrome. Remission following leg amputation, Semin. Arthritis Rheum., 31, 121, 10.1053/sarh.2001.27660 Espinosa, 2004, Thrombotic microangiopathic hemolytic anaemia and antiphospholipid antibodies, Ann. Rheum. Dis., 63, 730, 10.1136/ard.2003.007245 Asherson, 2005, Disseminated intravascular coagulation in the catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients, Ann Rheum. Dis., 10.1136/ard.2004.026377 Cervera, 2003, “CAPS Registry”: a review of 200 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS) (abstract), Ann. Rheum. Dis., 62, 88 Asherson, 2003, For the catastrophic registry project. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, Lupus, 12, 530, 10.1191/0961203303lu394oa Cervera, 2003, Catastrophic antiphospholipid syndrome (CAPS): analysis of the international consensus statement on preliminary classification criteria for CAPS using the “CAPS Registry” (abstract), Ann. Rheum. Dis., 62, 88 Erkan, 2004, Management of catastrophic antiphospholipid syndrome: plasma exchange or intravenous immunoglobulin, Lupus Flamholtz, 1999, Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta (2)-glycoprotein antibodies as a marker of response to therapy, J. Clin. Apher., 144, 171, 10.1002/(SICI)1098-1101(1999)14:4<171::AID-JCA3>3.0.CO;2-5 Kane, 1998, Catastrophic antiphospholipid antibody syndrome in primary systemic sclerosis, J. Rheumatol., 25, 810 Kovacs, 1991, Infusion of a stable prostacyclin analogue, Iloprost to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism, Am. J. Med., 90, 41, 10.1016/0002-9343(91)90504-Q Tedeschi, 1998, Thrombotic events in patients with systemic sclerosis treated with Iloprost, Arthritis Rheum., 41, 559, 10.1002/1529-0131(199803)41:3<559::AID-ART23>3.0.CO;2-M Dosekun, 1984, Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects, Arch. Intern. Med., 144, 37, 10.1001/archinte.144.1.37 Burcoglu-O'ral, 2002, Treatment of catastrophic antiphospholipid syndrome (CAPS) with defibrotide—a proposed vascular endothelial cell modulator, J. Rheumatol., 29, 2006 Erkan, 2003, Long-term outcome of catastrophic antiphospholipid syndrome survivors, Ann Rheum. Dis., 62, 530, 10.1136/ard.62.6.530 Erkan, 2003, Catastrophic antiphospholipid syndrome. Where do we stand?, Arthritis Rheum., 48, 3320, 10.1002/art.11359 Ehresmann S, Arkfeld D, Shinada S, Matyas SK, Liebman H. A novel therapeutic approach for Catastrophic Antiphospholipid Syndrome (CAPS) conventional therapy with anticoagulants and steroids were unsuccessful. Scientific Abstracts; 7th International Congress on SLE and Related Conditions. New York, May 2004, FR10278 pg 330.